Overview


According to FutureWise analysis the market for pacemaker device in 2023 is US$ 4.68 billion, and is expected to reach US$ 6.32 billion by 2031 at a CAGR of 3.80%.

A pacemaker monitors and regulates the heartbeat of patients through an implantable electronic device. Using small electric currents, it stimulates the body. Depending on the heart's needs, pacemakers can last for a short period of time or a long time. Pacemakers are also used to monitor the heartbeat and provide physiologic information. Patients with bradycardia, or a slow heart beat rate, will usually have pacemakers fitted. The pacemaker sends an electrical signal to the heart, increasing the pump rate when the heartbeat is too slow. There are three types of pacemakers: single, dual, and biventricular. In terms of arrhythmias, bradycardia and tachycardia are the two most common types. Bradycardia is when the heartbeat beats too fast. Tachycardia is when it beats too slowly. An arrhythmia is when the heart stops pumping enough blood to other parts of the body. This can cause fatigue and fainting. With no signs of coronary heart disease, the prevalence of arrhythmias atrial or ventricular increases with age. Pacemakers allow patients with arrhythmias to live a healthy and active lifestyle. There are two types: the implantable cardiac pacemaker and the external cardiac pacemaker. The implantable pacemaker is placed under the skin of the left chest. It is connected via leads that are guided through a blood vessel to connect to the heart. External cardiac pacemakers can be used temporarily and require a fully furnished clinical facility. Implantable pacemakers are more popular than external pacemakers. According to the patient's medical condition, doctors recommend either a single-chamber or dual-chamber pacemaker. Market growth in cardiac pacemakers is driven by the increasing incidence of atrial fibrillation (AFib), the most common type. The market is driven by rising incidences of Cardiovascular Diseases, increasing cost of managing cardiac disease, favorable government policies and the introduction technologically advanced pacemakers like leadless pacemakers or MRI safe pacemakers. Market growth is largely due to the rising incidence of CVDs. Global Cardiac Pacemaker Market Report provides an in-depth analysis of the market.

The market leaders in cardiac rhythm management devices have been focused on innovation and have invested more in R D to create enhanced pacemakers that offer better healthcare. The three-years have seen notable improvements in the innovative pacemaker devices, including miniaturization, complete magnet resonance imaging (MRI), compatibility, exceptional longevity with extended battery life, wireless remote monitoring and leadless pacemakers. Many leading players recently launch the MRI-conditional/compatible pacemakers by redesigning the components of pacemakers to minimize heating potential, dislodgement, current induction, and electromagnetic interference. The pacemaker market will grow due to the rising prevalence of cardiovascular disease among the millennials and the aging population. The pacemaker market has seen a significant increase in demand due to increasing cardiovascular disease prevalence.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Pacemaker Device Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Pacemaker Device Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • OSYPKA MEDICAL
  • Boston Scientific Corporation
  • Zoll Medical Corporation, an Asahi Kasei Group Company
  • Medtronic
  • BIOTRONIK SECo. KG
  • MEDICO S.R.L.
  • Shree Pacetronix Ltd.
  • Abbott
  • OSCOR Inc.
  • Lepu Medical Technology(Beijing)Co.,Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Implantable Pacemakers
  • Dual Chamber
  • Biventricular Chamber
  • External Pacemakers

By Type

  • MRI Compatible Pacemakers
  • Conventional Pacemakers

By Application

  • Arrhythmias
    • Atrial Fibrillation
    • Heart Block
    • Long QT Syndrome
  • Congestive Heart Failure
  • Others

By End-Use

  • Hospitals and Cardiac Centers
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Pacemaker Device Market By Product, By Type, By Application, By End-Use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Pacemaker Device Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Pacemaker Device Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Pacemaker Device Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Pacemaker Device Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Implantable Pacemakers
        2. Dual Chamber
        3. Biventricular Chamber
        4. External Pacemakers

  • 8.   Pacemaker Device Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. MRI Compatible Pacemakers
        2. Conventional Pacemakers

  • 9.   Pacemaker Device Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Arrhythmias
         1.1. Atrial Fibrillation
         1.2. Heart Block
         1.3. Long QT Syndrome
        2. Congestive Heart Failure
        3. Others

  • 10.   Pacemaker Device Market, By End-Use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals and Cardiac Centers
        2. Ambulatory Surgical Centers
        3. Others

  • 11.   North America Pacemaker Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Pacemaker Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Pacemaker Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Pacemaker Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. OSYPKA MEDICAL
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Boston Scientific Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Zoll Medical Corporation, an Asahi Kasei Group Company
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Medtronic
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. BIOTRONIK SECo. KG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. MEDICO S.R.L.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Shree Pacetronix Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Abbott
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. OSCOR Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Lepu Medical Technology(Beijing)Co.,Ltd.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients